WENDY SHORT: Open Payments
NPI 1073854733 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,042 in 74 payments from 22 companies in 2025. Trend: 2023 $1,657 · 2024 $2,881 · 2025 $3,042
Food & beverage: $3,022Education: $20
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $487 |
| Boston Scientific Corporation | 5 | $355 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $339 |
| Novo Nordisk Inc | 2 | $221 |
| Novartis Pharmaceuticals Corporation | 10 | $191 |
| Alnylam Pharmaceuticals Inc. | 4 | $159 |
| Gilead Sciences, Inc. | 1 | $150 |
| Averitas Pharma Inc. | 2 | $150 |
| Shockwave Medical, Inc | 1 | $129 |
| GENZYME CORPORATION | 1 | $125 |
Products named: REPATHA, Kerendia, Wegovy, WATCHMAN FLX, LEQVIO, Livdelzi, QUTENZA, General - Vascular Intervention.
Industry payments across TX — which companies pay providers there.
